Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Endocrinology 3, 790 (1 December 2007) | doi:10.1038/ncpendmet0652
Highly sensitive thyroglobulin assay is useful in the follow-up of patients treated for DTC
Abstract
Iervasi A et al. (2007) Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol 67: 434–441 Serum thyroglobulin is a highly specific marker for residual thyroid tissue and/or recurrence or metastases in patients previously treated for differentiated thyroid cancer (DTC).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
